Page last updated: 2024-11-06

benzimidazole and Psoriasis

benzimidazole has been researched along with Psoriasis in 1 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, S1
Liu, D1
Shen, R1
Li, D1
Hu, Q1
Yan, Y1
Sun, J1
Zhang, F1
Wan, H1
Dong, P1
Feng, J1
Zhang, R1
Li, J1
Zhang, L1
Tao, W1

Other Studies

1 other study available for benzimidazole and Psoriasis

ArticleYear
Discovery of a novel RORĪ³ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis.
    Scientific reports, 2021, 04-28, Volume: 11, Issue:1

    Topics: Administration, Topical; Animals; Benzimidazoles; Binding Sites; Disease Models, Animal; Drug Evalua

2021